During the late luteal phase of the menstrual cycle and early pregnancy, the major secretory product of the uterine glandular epithelial cells in humans and non-human primates is glycodelin. Previous studies using Ishikawa cells, a human endometrial cell line, have shown that a chimeric plasmid containing the baboon glycodelin promoter responds to progestins but the response is modest compared with the induction of glycodelin seen in vivo and in gene array analysis. A recent report indicating that the histone deacetylase inhibitor trichostatin A (TSA) promoted glycodelin expression prompted us to examine its mechanism of action. In Ishikawa cells transfected with the baboon glycodelin promoter, TSA and the synthetic progestin medroxyprogesterone acetate both stimulated expression of the reporter and the combined treatment produced a synergistic effect. The effect of TSA and progestin was absent when the same promoter constructs were transfected into COS-1 cells, a kidney cell line, and a TSA effect but no progestin effect was observed in T47D cells, a mammary cell line. Through deletion analysis, the TSA action was localized to the K67/K52 region of the baboon glycodelin promoter, a region which contains the proximal Sp1 site. Deletions of this same region had no effect on progestin responsiveness. Our findings indicate that at least two regions of the glycodelin promoter are important for the normal induction of glycodelin expression. Non-target cells may lack factors which act on the response elements resulting in the restriction of expression to the appropriate target tissue.
Introduction
Glycodelin, a 28 kDa glycoprotein, is the most abundant secretory product of the human uterine glandular epithelial cells during the late luteal phase of the menstrual cycle and early pregnancy (Bell et al. 1985) . In a non-human primate model, the baboon, glycodelin synthesis begins in the mid-luteal phase of the menstrual cycle and increases dramatically during early pregnancy (Hausermann et al. 1998) . Gene expression profiling has shown that glycodelin is the most abundant transcript in the human endometrium during these phases (Kao et al. 2002 , Borthwick et al. 2003 , Riesewijk et al. 2003 . In several conditions where the reproductive success rate is low, such as endometriosis, the expression of glycodelin is drastically curtailed (Kao et al. 2003) . Proposed functions for glycodelin in reproduction include inhibition of sperm binding to the zona pellucida (Oehninger et al. 1995) and suppression of the immune response during early pregnancy (Bolton et al. 1987) .
Progestins have been shown to induce glycodelin expression in isolated human uterine epithelial cells (Taylor et al. 1998) . Although computer analysis of the human glycodelin promoter identified a potential progesterone response element (Vaisse et al. 1990 ), functional studies have found that it is not involved in the progestin induction (Gao et al. 2001 , Jaffe et al. 2003 . In the human glycodelin promoter, Gao et al. (2001) showed that the progestin-mediated induction is dependent on several Sp1 sites. In the structurally similar baboon glycodelin promoter, we found that the Sp1 sites were not necessary for the progestin-mediated induction (Jaffe et al. 2003 (Jaffe et al. , 2006 . The progestin-mediated induction was, however, blunted by inhibition of the extracellular signal regulated kinase (ERK)1/2 branch of the mitogen activated protein kinase (MAPK) pathway (Jaffe et al. 2006) . In Ishikawa cells, the production of glycodelin has also been shown to be induced by histone deacetylase (HDAC) inhibitors (Uchida et al. 2005) .
In this manuscript, we report that in Ishikawa cells an HDAC inhibitor and progestin act synergistically on the baboon glycodelin promoter. We find that the most proximal Sp1 element is sufficient and required for the trichostatin A (TSA) effect. In COS-1 cells, a kidney cell line from African green monkeys, both the synthetic progestin medroxyprogesterone acetate (MPA) and TSA are ineffective while in T47D cells, a human mammary tumor cell line containing the progesterone receptor, TSA was effective but MPA was not in inducing reporter gene expression and there was no synergism between TSA and MPA. Thus, maximal expression of the glycodelin gene relies on factors involved in the nongenomic pathway of progestin stimulation and inhibition of HDAC either of which may be restricted to target tissues providing a mechanism for the target tissue specific expression of glycodelin in high amounts.
Materials and methods

Materials
pGL3Basic, b-galactosidase enzyme assay system, and luciferase assay system were purchased from Promega. pCMVSport-b-galactosidase, Dulbecco's modified Eagle medium (DMEM), phenol red-free DMEM, fetal bovine serum (FBS), and other tissue culture supplies were obtained from Invitrogen. TSA and bovine insulin were obtained from Sigma-Aldrich. The human progesterone receptor B (PRB) expression plasmid and progesterone response element (PRE)-luciferase plasmids were a gift from Dr Ming-Jer Tsai (Baylor College of Medicine, Houston, TX, USA).
Plasmid constructions
The generation of the 5 0 deletions was carried out by introducing NheI restriction sites into the K68/C48 region (the transcriptional start site numbered C1) of the baboon glycodelin promoter within the pGL3Basic reporter plasmid as described previously (Jaffe et al. 2006 ) using the procedure of Ho et al. (1989) . Each of the constructs was confirmed by sequencing. The 5 0 deletions were created by digesting with NheI and MluI and then the Klenow fragment of DNA polymerase I was used to fill in the overhangs. The plasmids were purified by agarose gel electrophoresis and ligated. All plasmids were sequenced to verify that the promoter had the expected deletions by the DNA Sequencing Facility of the UIC Research Resources Center.
Cell culture, transfection, and luciferase assay Ishikawa and COS-1 cells were cultured in DMEM supplemented with 10% FBS, 100 IU/ml penicillin, and 100 mg/ml streptomycin in a 37 8C incubator with a humidified atmosphere and 5% CO 2 . T47D cells were cultured in RPMI 1640 media containing 10% FBS, 0 . 2 U/ml bovine insulin, 100 IU/ml penicillin, and 100 mg/ml streptomycin. On the day before the transfections, the cells were plated at a concentration of 1 . 1! 10 5 cells/cm 2 in 12-well plates in phenol red-free DMEM supplemented with 2% charcoal-stripped FBS (Ishikawa and COS-1 cells) or 5% charcoal-stripped FBS plus 0 . 2 U/ml bovine insulin (T47D cells), 100 U/ml penicillin, and 100 mg/ml streptomycin. The cells were transfected in triplicate with plasmids using the calcium phosphate precipitation method (Sambrook et al. 1989) as we have described previously (Jaffe et al. 2003 (Jaffe et al. , 2006 with each well receiving 0 . 25 mg pCMVSport-b-galactosidase, 1 . 25 mg luciferase reporter plasmid, and 1 . 25 mg PRB expression plasmid. We have previously shown that under our culture conditions our line of Ishikawa cells do not exhibit functional progesterone receptor activity (Jaffe et al. 2003 (Jaffe et al. , 2006 . After a 4-h incubation with the plasmid, the cells were washed, glycerol shocked, and placed in the treatment media which included either 1 mM MPA or an equal volume of the vehicle, ethanol, and either TSA at the indicated concentration or its vehicle, DMSO, for 24 h. The cell lysates were prepared in reporter lysis buffer and the luciferase activity was measured with the luciferase assay system and the b-galactosidase with the b-galactosidase enzyme assay system.
Statistical analysis
Data are expressed as the meanGS.D. of three independent experiments. To stabilize the variance, log-transformed data were analyzed. To compare different conditions, ANOVA as well as Tukey's multiple comparison test were used. Differences were considered statistically significant at P!0 . 05. Analyses were performed using statistical analysis system (SAS), mainly PROC ANOVA (version 9.1, SAS Institute, Cary, NC, USA).
Results
In Ishikawa cells, a human endometrial cell line, co-transfected with the K67/C48Glycodelin-pGL3Ba-sic plasmid and PRB expression plasmid, the addition of the HDAC inhibitor TSA to the media for 24 h produced a concentration-dependent increase in luciferase expression (Fig. 1a) . When compared with vehicle-treated cells (0 nM TSA), the addition of 250 or 500 nM TSA to the media produced a significant increase in luciferase expression. At the highest concentration of TSA utilized, 500 nM, there was an approximately 13-fold induction in luciferase levels. As depicted in the right half of Fig. 1a , the same concentration of TSA had no effect on cells transfected with the pGL3Basic plasmid and only a slight effect on cells transfected with the PRE plasmid (Fig. 1a , right panel). When Ishikawa cells were co-transfected with theK67/C48Glycodelin-pGL3Basic and PRB expression plasmids and treated with MPA, there was a greater than sixfold increase in luciferase expression (0 nM TSA lane Fig. 1c ). Addition of both MPA and various concentrations of TSA to the media produced a synergistic induction of luciferase expression ( Fig. 1b) with a 136-fold induction at the highest level of TSA tested. The response was dependent on the glycodelin promoter as in Ishikawa cells transfected with the pGL3Basic vector, there was only a minor effect of TSA and MPA together (Fig. 1b) . The response of the Ishikawa cells co-transfected with the K67/C48Glyco-delin-pGL3Basic and PRB expression plasmids to the synthetic progestin MPA was significant at all levels of TSA tested and the magnitude of the response was only slightly increased, from 6-to 11-fold, as the concentrations of TSA increased (Fig. 1c) . This difference was only significant for the cells treated with 250 nM TSA as compared with the cells treated with vehicle alone. A reporter plasmid containing a PRE when co-transfected into the Ishikawa cells with the PRB expression plasmid was highly responsive to progesterone (Fig. 1c , right-hand panel) but displayed no synergism between TSA and MPA (Fig. 1b, right-hand panel) . Computer analysis of the human (Vaisse et al. 1990 ) and baboon (Jaffe et al. 2003) glycodelin promoter identified several potential response elements upstream of K67. We have previously shown (Jaffe et al. 2003 ) that this region is not required for the progestin response. To examine if this region plays a role in the responsiveness of the glycodelin promoter to the HDAC inhibitor TSA, we examined the effects of MPA and TSA on larger constructs of the glycodelin promoter (Fig. 2) . The effect of TSA alone on the K2007/C48 and K368/C48Glycodelin-pGL3Basic constructs of the baboon glycodelin promoter was similar to the effect of TSA on the response of the K67/C48Glycodelin-pGL3Basic construct. These TSA (nM) Figure 1 Effect of TSA concentration on the responsiveness of the K67/C48Glycodelin-pGL3Basic, pGL3Basic, and PRE reporter plasmids in the presence and the absence of MPA in Ishikawa cells. Ishikawa cells were co-transfected with the PRB expression plasmid, pCMVSport-b-galactosidase, and either the constructs were also responsive to MPA as we have previously reported (Jaffe et al. 2003) . A synergistic response was observed when TSA and MPA were added to the media of Ishikawa cells co-transfected with the construct and the PRB. However, the K2007/C48 and the K368/C48 constructs exhibited no greater response than the K67/C48 region of the glycodelin promoter.
COS-1 cells, a kidney cell line derived from African green monkeys, co-transfected with various constructs of the glycodelin promoter (K2007/C48, K368/C48, and K67/C48) in pGL3Basic and the PRB expression vector do not exhibit a response to MPA (Fig. 3) as we have previously reported (Jaffe et al. 2003) . TSA treatment of the COS-1 cells co-transfected with any of the glycodelin promoter constructs and the PRB expression vector did not produce any response greater than controls. A synergistic response to TSA and MPA was obtained with the K2007/C48 and the K67/C 48Glycodelin-pGL3 constructs but it was minor compared with that seen with the same constructs in Ishikawa cells. Similarly, MPA had no effect on the same glycodelin promoter constructs in T47D cells, a human mammary ductal cell line (Fig. 4, left panel) . This cell line contains an endogenous PR and MPA greatly increases luciferase levels in T47D cells transfected with the PRE promoter (Fig. 4, right panel) . Unlike in the COS-1 cells, the various baboon glycodelin reporter constructs exhibited an increase in luciferase expression in response to TSA, but there was no synergism between TSA and MPA when the media contained both factors.
To determine the region of the glycodelin promoter responsible for the TSA responsiveness in the Ishikawa cells, we made serial deletions from the 5 0 end of the K67/C48Glycodelin promoter. Deletion of 15 bp from the 5 0 end producing the K52/C48 glycodelin promoter completely abolished the TSA responsiveness (Fig. 5 ). All further reductions had a response to TSA identical to that of the pGL3Basic vector alone. Removal of the region between K67 and K52 of the glycodelin promoter had no effect on the responsiveness to MPA (Fig. 6) . Further 10 bp deletions of this region of the baboon glycodelin promoter had little effect on the responsiveness to MPA with only the deletion to K22 having a significantly lower response to the synthetic progestin than the K52/C48Glycodelin construct. 
Discussion
Glycodelin is the major secretory product of the human (Bell et al. 1985) and non-human (Hausermann et al. 1998) primate uteri during the late luteal phase of the menstrual cycle and early pregnancy. Analysis of the expression profile using gene arrays (Kao et al. 2002 , Borthwick et al. 2003 , Riesewijk et al. 2003 shows that glycodelin mRNA steady-state levels are also elevated. During the luteal phase of the menstrual cycle and in early pregnancy progesterone levels are elevated. Taylor et al. (1998) have shown in isolated human epithelial cells that progesterone is able to induce glycodelin expression. In our previous studies (Jaffe et al. 2003 (Jaffe et al. , 2006 and those of Gao et al. (2001) , it was shown that the progestin induction of the baboon and human glycodelin promoter required the progesterone receptor and did not depend upon a canonical progesterone response element. The induction was retained when the DNA-binding domain of the progesterone receptor was mutated and did not depend on Sp1 response elements (Jaffe et al. 2006) . Because the MAPK inhibitor PD98059 blunted the progestin responsiveness of the glycodelin promoter, we proposed that the induction of the glycodelin expression by the PR in a progestin-dependent fashion was non-genomic. In our previous studies (Jaffe et al. 2003 (Jaffe et al. , 2006 ) and those of Gao et al. (2001) , the glycodelin promoter response to progestins was quite modest in comparison with the robust changes in expression that occur in vivo as seen on gene arrays (Kao et al. 2002, Borthwick et 2003, Riesewijk et al. 2003) . The recent report of Uchida et al. (2005) that the HDAC inhibitor TSA induced glycodelin expression in Ishikawa cells prompted us to explore the interaction between these factors on the glycodelin promoter. Our hypothesis was that the induction of glycodelin expression seen in vivo was due to the multiple factors acting together. Our finding that TSA increased luciferase expression in Ishikawa cells transfected with the K67/C48 region of the baboon glycodelin promoter in a dose-dependent manner up to concentrations of 500 nM are consistent with the report of Uchida et al. (2005) on the effect of various concentrations of TSA on glycodelin protein and mRNA levels in Ishikawa cells. The effect of TSA was not a promiscuous one as it had little effect on pGL3Basic, the vector in which the glycodelin promoter resided, no effect on the glycodelin promoter in COS-1 cells or on a reporter containing a PRE. At the maximum levels of TSA tested, 500 nM, the effect of TSA alone on the K67/C48Glycodelin-pGL3Basic reporter plasmid in Ishikawa cells was slightly greater than the effect of the progestin alone. When both MPA and TSA were added to the media there was a significant synergistic effect. This effect was not due to a change in the effectiveness of MPA on the promoter. Within the K67/C48 region of the baboon glycodelin promoter is a single Sp1 site at K55/K50. In various systems, HDACs have been shown to tether to the Sp1 transcription factor at the Sp1 response element (reviewed in Li et al. 2004) . Our deletion analysis reveals that the region of the baboon glycodelin promoter containing the Sp1 element is critical for the TSA effect. In the larger fragments (K2007/C48 and K368/C48) of the baboon glycodelin promoter tested there are two additional Sp1 elements. These elements do not seem to be important for the effect of TSA or for the synergism between MPA and TSA as neither of the larger fragments gave a better response than the K67/C48 fragment which contains a single Sp1 element.
Interestingly, in COS-1 cells, the same baboon glycodelin promoter, previously shown in this cell line to be unresponsive to MPA, failed to show a response to TSA or a synergism between MPA and TSA. We previously showed that while the glycodelin promoter will not respond to progestin in COS-1 cells, a PRE is still responsive to progestin (Jaffe et al. 2003) . In T47D cells, a mammary ductal tumor cell line, which contains a PR there is also no response of the glycodelin promoter to MPA. However, unlike the COS-1 cells, the T47D cells do exhibit a response to TSA but there is no synergism between MPA and TSA. We believe these findings imply that the cell specific expression of glycodelin is due to specific factors in both the pathway by which progesterone is able to activate the glycodelin gene, absent in both COS-1 and T47D cells, as well as the components responsible for increased glycodelin expression in response to HDAC inhibition, absent in the COS-1 cells but not in the T47D cells. This may account for the previous observation that glycodelin is expressed in the human mammary gland but it is not regulated by progesterone (Kamarainen et al. 1999) . It has been shown in a number of other genes that HDAC may interact with Sp1 which in turn is bound to the Sp1 element (reviewed in Li et al. 2004) . Our results of the progressive deletion studies demonstrating that the deletion of the region between K67 and K52 of the glycodelin promoter completely obliterates the response to TSA suggest this is the mechanism by which HDAC inhibition affects glycodelin gene expression. That the TSA and progestin effects are independent is supported by the finding that deletions in this same region do not alter the responsiveness to progestin. Furthermore, since the level of expression of the reporter is elevated when the HDAC activity is inhibited but is not elevated when the site to which the HDAC is tethered is removed, we would hypothesize that the TSA induction of glycodelin expression is not simply the removal of the HDAC but requires the subsequent recruitment of a histone acetyltransferase with subsequent acetylation of histones of the nucleosome.
